Pharming Group NV
AEX:PHARM
Pharming Group NV
Net Income (Common)
Pharming Group NV
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharming Group NV
AEX:PHARM
|
Net Income (Common)
-$10.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Net Income (Common)
-€26.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Net Income (Common)
-$296.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-22%
|
|
argenx SE
XBRU:ARGX
|
Net Income (Common)
-$429.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Merus NV
NASDAQ:MRUS
|
Net Income (Common)
-$149.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Net Income (Common)
-€78.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharming Group NV's Net Income (Common)?
Net Income (Common)
-10.8m
USD
Based on the financial report for Mar 31, 2024, Pharming Group NV's Net Income (Common) amounts to -10.8m USD.
What is Pharming Group NV's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
8%
Over the last year, the Net Income (Common) growth was -441%.